Scarica l'app Stockscreener
10.83
2.46%
0.26
Dopo l'orario di chiusura:
10.83
Precedente Chiudi:
$10.57
Aprire:
$9.28
Volume 24 ore:
38,672
Relative Volume:
0.28
Capitalizzazione di mercato:
$167.40M
Reddito:
$54,000
Utile/perdita netta:
$-210.26M
Rapporto P/E:
-13.71
EPS:
-0.79
Flusso di cassa netto:
$-159.01M
1 W Prestazione:
-2.26%
1M Prestazione:
+11.08%
6M Prestazione:
-6.96%
1 anno Prestazione:
-60.47%
Intervallo 1D:
$9.28
$10.83
Intervallo di 1 settimana:
$9.28
$12.00
Portata 52W:
$7.65
$32.40
Lyell Immunopharma Inc Stock (LYEL) Company Profile
Nome
Lyell Immunopharma Inc
Settore
Industria
Telefono
650 695-0677
Indirizzo
201 HASKINS WAY, SOUTH SAN FRANCISCO
Confronta LYEL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LYEL
Lyell Immunopharma Inc
|
10.83 | 203.06M | 54,000 | -210.26M | -159.01M | -0.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Lyell Immunopharma Inc Stock (LYEL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-30 | Downgrade | BofA Securities | Buy → Underperform |
| 2024-06-27 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2023-08-28 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-11-14 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-11-11 | Downgrade | Goldman | Buy → Neutral |
| 2022-10-17 | Iniziato | H.C. Wainwright | Buy |
| 2021-07-12 | Iniziato | BofA Securities | Buy |
| 2021-07-12 | Iniziato | Goldman | Buy |
| 2021-07-12 | Iniziato | JP Morgan | Overweight |
| 2021-07-12 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Lyell Immunopharma Inc Borsa (LYEL) Ultime notizie
Real time scanner hits for Lyell Immunopharma Inc. explained2025 Market Sentiment & Safe Entry Point Alerts - Newser
Lyell Immunopharma: Q2 Earnings Snapshot - New Haven Register
Identifying reversal signals in Lyell Immunopharma Inc.July 2025 Chart Watch & AI Forecasted Entry and Exit Points - Newser
Will Lyell Immunopharma Inc. rebound enough to break evenMarket Performance Recap & Fast Gaining Stock Strategy Reports - Newser
Lyell Immunopharma 2025 Q2 Earnings Slight Improvement in Losses Amid Revenue Drop - AInvest
Forex Signals Brief for Aug 13: Cisco, Trump Media, Lyell Earnings in Focus - FXLeaders
Regression analysis insights on Lyell Immunopharma Inc. performanceReal-Time Setup Summary with ROI Focus - Newser
Intraday pattern recognizer results for Lyell Immunopharma Inc.Oversold Stock Bounce Playbook Generator - Newser
Lyell Immunopharma Reports Positive Clinical Data, $100mln Private Placement. - AInvest
Lyell Immunopharma's Share Sale and Its Implications for Market Confidence and Capital Flexibility - AInvest
Lyell Immunopharma Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2025 - GlobeNewswire
Is Lyell Immunopharma Inc. stock poised for growthSwing Entry Risk Mitigation with Chart Analysis - Newser
What technical models suggest about Lyell Immunopharma Inc.’s comebackChart-Based Entry Confirmation for Beginners - Newser
How Lyell Immunopharma Inc. stock performs during market volatilityHigh Yield Growth Opportunities - mustnews.co.kr
Will earnings trigger a reversal in Lyell Immunopharma Inc.Risk Aware Trading Ideas with Alert Levels - Newser
What’s next for Lyell Immunopharma Inc. stock priceReversal Pattern Insights with Entry Tips - Newser
Published on: 2025-08-10 21:20:55 - Newser
Can you recover from losses in Lyell Immunopharma Inc.Free Short Term Buy Zone Stock Alerts - Newser
Applying big data sentiment scoring on Lyell Immunopharma Inc.Downside Risk Evaluation and Stock Analysis - Newser
Reversal Confirmed Lyell Immunopharma Inc. Stock Rallies Above MAAI Based High Gain Watchlist Scanner Shared - beatles.ru
Visual trend scoring systems applied to Lyell Immunopharma Inc.Daily Trade Setup Forecast with Confidence - Newser
Custom strategy builders for tracking Lyell Immunopharma Inc.Buy Candidate Summary Based on Fundamentals - Newser
How to use a screener to detect Lyell Immunopharma Inc. breakoutsHistorical Market Behavior and Trend Summary - Newser
Analyzing drawdowns of Lyell Immunopharma Inc. with statistical toolsSwing Trade Signal and Price Prediction - Newser
Analyzing recovery setups for Lyell Immunopharma Inc. investorsDownside Risk Evaluation and Stock Analysis - Newser
Should you wait for a breakout in Lyell Immunopharma Inc.Forecasting Stock Moves with AI Insights - Newser
What makes Lyell Immunopharma Inc. stock price move sharplyBuild a strong portfolio for growth and safety - Jammu Links News
Lyell Immunopharma Inc. Stock Analysis and ForecastUnlock exclusive stock market forecasts - Jammu Links News
When is Lyell Immunopharma Inc. stock expected to show significant growthSuperior trading gains - Jammu Links News
What institutional investors are buying Lyell Immunopharma Inc. stockBuild a diversified portfolio for risk mitigation - Jammu Links News
Should I hold or sell Lyell Immunopharma Inc. stock in 2025Outstanding trading profits - Jammu Links News
Does Lyell Immunopharma Inc. stock perform well during market downturnsUnlock powerful market insights for success - Jammu Links News
How strong is Lyell Immunopharma Inc. company’s balance sheetInvest smarter with data-backed trading alerts - Jammu Links News
What catalysts could drive Lyell Immunopharma Inc. stock higher in 2025Get expert alerts on market-moving stocks - Jammu Links News
Why Lyell Immunopharma Inc. stock attracts strong analyst attentionSecure Buy Strategy Based on Risk Parameters - Newser
Is Lyell Immunopharma Inc. a growth stock or a value stockStock Market Picks With High Returns - jammulinksnews.com
Lyell Immunopharma Inc Azioni (LYEL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):